‘Major milestone’ for UK clinical trials as new framework laid in parliament
The framework seeks to make the UK a desirable clinical trials location by expediting approvals and raising participant diversity.
Corporate Governance
MHRA trials innovative AI technologies to consider regulatory approach
RFK’s regulatory plans could overburden small manufacturers, says analyst
Dr Oz nominated to lead CMS despite big pharma ties
Trump 2.0 spells uncertainty for US healthcare, says analyst
US maternal care failings due to ‘focus on reactive care’
FDA’s final rule on LDTs causes concern, but timeline looks unsteady
Reeves’ 2024 budget promises life sciences investment
